• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Treatment for Parkinson's OFF Periods: Istradefylline David Orchard-Webb
    July 01, 2024
    Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain.One promising treatment for managing these off periods is Istradefylline, an adenosine A2A receptor antagonist.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service